Matrix metalloproteinases (MMPs) and tissue inhibitors (TIMPs) play a key role in the pathogenesis of multiple sclerosis (MS) and have been proposed as biomarkers of response to therapy. We investigated serum levels of several MMPs and TIMPs in 43 relapsing-remitting MS (RRMS) patients undergoing in...
Bibliographische Detailangaben
| Veröffentlicht in: | Clinical immunology (Orlando, Fla.). - 1999. - 130(2009), 2 vom: 11. Feb., Seite 145-50
|
|---|
| 1. Verfasser: |
Comabella, Manuel
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Río, Jordi,
Espejo, Carmen,
Ruiz de Villa, Mamen,
Al-Zayat, Hammad,
Nos, Carlos,
Deisenhammer, Florian,
Baranzini, Sergio E,
Nonell, Lara,
López, Cristina,
Julià, Eva,
Oksenberg, Jorge R,
Montalban, Xavier |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | English |
|---|
| Veröffentlicht: |
2009
|
|---|
| Zugriff auf das übergeordnete Werk: | Clinical immunology (Orlando, Fla.)
|
|---|
| Schlagworte: | Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Immunologic Factors
Tissue Inhibitor of Metalloproteinase-1
Tissue Inhibitor of Metalloproteinase-2
127497-59-0
Interferon-beta
77238-31-4
Matrix Metalloproteinase 7
mehr...
EC 3.4.24.23
Matrix Metalloproteinase 2
EC 3.4.24.24
Matrix Metalloproteinase 9
EC 3.4.24.35 |
|---|